WebDisclosure WebDisclosure
Basculer en Français
8722 Companies
153294 Keywords
88826 Articles
82388 Press releases
Headlines Articles Press releases ShoulderMaster Remove
  1. Home
  2. Companies
  3. ShoulderMaster
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 01/16/2024 at 14:00, 1 year 5 months ago

    ShoulderMaster and ALMACO Join Forces for Innovative Road Construction Solutions

    ShoulderMaster and ALMACO are proud to announce their manufacturing and engineering partnership, aiming to advance road construction technology and sustainability. ShoulderMaster, a leader in purpose-built road construction equipment, is set to benefit from ALMACO's manufacturing and engineering services, aligning with their shared values of quality, innovation, and safety. The partnership's collaborative efforts are expected to make a lasting impact on the road construction industry by fostering innovation and redefining benchmarks for achieving road construction goals.
    Sustainability ShoulderMaster ALMACO Road Construction Technology Engineering Partnership
Accesswire
  • Published on 06/18/2025 at 15:15, 1 hour 19 minutes ago

    Telomir Pharmaceuticals Prevents Cellular Aging in Patient-Derived Cells from Children with Progeria - an Ultra-Rare Genetic Disorder that Causes Rapid Aging

  • Published on 06/18/2025 at 15:00, 1 hour 34 minutes ago

    iAccess Alpha's Virtual Best Ideas Summer Investment Conference June 24-25, 2025

  • Published on 06/18/2025 at 14:50, 1 hour 44 minutes ago

    Rio Grande Resources Announces Positive Assay Results From its Sampling and Field Campaign at the Winston Gold-Silver Project, New Mexico USA

  • Published on 06/18/2025 at 14:30, 2 hours 4 minutes ago

    Brenmiller Energy Comments on Reverse Share Split Ahead of Expected Near-Term Milestones

  • Published on 06/18/2025 at 14:30, 2 hours 4 minutes ago

    MIRA Pharmaceuticals' Lead Drug Candidate Ketamir-2 First Manuscript Accepted for Publication in the Peer-Reviewed Journal Frontiers in Pharmacology

View all ACCESSWIRE
EQS Group
  • Published on 06/18/2025 at 16:14, 20 minutes ago

    EQS-Adhoc: Hamburger Hafen und Logistik AG: Majority shareholder submits counterproposal to reduce dividend

  • Published on 06/18/2025 at 16:14, 20 minutes ago

    Dalata Hotel Group PLC: HOL-Holding(s) in Company*

  • Published on 06/18/2025 at 16:11, 23 minutes ago

    Coinsilium Group Limited: Forza! Bitcoin Treasury Update

  • Published on 06/18/2025 at 16:05, 29 minutes ago

    Annual General Meeting of Eckert & Ziegler SE Approves Dividend of EUR 0.50

  • Published on 06/18/2025 at 16:00, 34 minutes ago

    Changes in the Executive Board of GRAMMER AG

View all EQS
Les Echos
  • Published on 06/18/2025 at 14:21, 2 hours 13 minutes ago

    Definitieve resultaten van de kapitaalverhoging

  • Published on 06/18/2025 at 14:21, 2 hours 13 minutes ago

    Final results of the capital increase

  • Published on 06/18/2025 at 14:21, 2 hours 13 minutes ago

    Final results of the capital increase

  • Published on 06/18/2025 at 09:39, 6 hours 55 minutes ago

    Eerste fase van het openbaar aanbod in het kader van een kapitaalverhoging is succesvol afgerond waarbij reeds werd ingeschreven op ongeveer 75,56% van de Nieuwe Aandelen Lancering van een versnelde private plaatsing van Scrips

  • Published on 06/18/2025 at 09:39, 6 hours 55 minutes ago

    First phase of the public offering in the framework of the capital increase has been successfully completed with about 75.56% of the New Shares already subscribed Launch of an accelerated private placement of Scrips

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy